Baidu
map

Diabetologia:现代治疗方案降低1型糖尿病患者低血糖发生

2013-09-09 佚名 丁香园

严重低血糖是最佳血糖控制的最主要障碍。然而,近期治疗方法的改变可以导致严重低血糖流行病学和其相关危险因素变化。为了探讨当代1型糖尿病青少年儿童队列中严重低血糖相关发病率和危险因素,来自澳大利亚西澳大学Timothy W Jones教授及其团队进行了一项研究,该研究发现当代治疗方案与严重低血糖模式和发生率改变有关。该研究结果发表在2013年10月的《Diabetologia》

严重低血糖是最佳血糖控制的最主要障碍。然而,近期治疗方法的改变可以导致严重低血糖流行病学和其相关危险因素变化。为了探讨当代1型糖尿病青少年儿童队列中严重低血糖相关发病率和危险因素,来自澳大利亚西澳大学Timothy W Jones教授及其团队进行了一项研究,该研究发现当代治疗方案与严重低血糖模式和发生率改变有关。该研究结果发表在2013年10月的《Diabetologia》杂志上。【原文下载】

该研究中,从西澳州一个以人群为基础的登记处鉴定受试者,包含数据中大于99%的患者(年龄<16岁)正在接受1型糖尿病治疗。患者大约每3个月复诊一次,前瞻性记录与糖尿病管理、人口统计资料和并发症(包括低血糖)有关的数据。严重低血糖事件定义为低血糖相关昏迷或惊厥事件。评估的危险因素包括年龄、糖尿病病程、血糖控制、性别、胰岛素治疗、社会经济状况和治疗时间。

该研究结果表明,2000年到2011年期间对来自1770例患者的8213人年的数据进行分析。随访期间,观察到841次严重低血糖发作。不同年龄组之间没有观察到严重低血糖风险的差异。与平均HbA1c 8-9%组相比,血糖控制良好(HbA1c<7%)组与严重低血糖风险增加无关。当与注射方案的患者相比,胰岛素泵治疗的年龄12-18岁受试者严重低血糖风险降低。

该研究发现,在这个以人群为基础的青少年儿童1型糖尿病样本中,现代治疗方案与严重低血糖模式和发生率改变有关。

原文下载

Cooper MN, O'Connell SM, Davis EA, Jones TW.A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes.Diabetologia. 2013 Oct;56(10):2164-70. doi: 10.1007/s00125-013-2982-1. Epub 2013 Jul 6.


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1759341, encodeId=934b1e59341c9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Feb 05 17:11:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636736, encodeId=0c3a1636e36d9, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 10 05:11:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904933, encodeId=6a2e1904933cc, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Tue Jun 17 18:11:00 CST 2014, time=2014-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968169, encodeId=e3df196816969, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=675, encryptionId=a4b96e542, topicName=1型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Thu Aug 14 08:11:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473740, encodeId=82f014e3740bc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Sep 11 02:11:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1759341, encodeId=934b1e59341c9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Feb 05 17:11:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636736, encodeId=0c3a1636e36d9, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 10 05:11:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904933, encodeId=6a2e1904933cc, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Tue Jun 17 18:11:00 CST 2014, time=2014-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968169, encodeId=e3df196816969, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=675, encryptionId=a4b96e542, topicName=1型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Thu Aug 14 08:11:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473740, encodeId=82f014e3740bc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Sep 11 02:11:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1759341, encodeId=934b1e59341c9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Feb 05 17:11:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636736, encodeId=0c3a1636e36d9, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 10 05:11:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904933, encodeId=6a2e1904933cc, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Tue Jun 17 18:11:00 CST 2014, time=2014-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968169, encodeId=e3df196816969, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=675, encryptionId=a4b96e542, topicName=1型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Thu Aug 14 08:11:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473740, encodeId=82f014e3740bc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Sep 11 02:11:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1759341, encodeId=934b1e59341c9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Feb 05 17:11:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636736, encodeId=0c3a1636e36d9, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 10 05:11:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904933, encodeId=6a2e1904933cc, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Tue Jun 17 18:11:00 CST 2014, time=2014-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968169, encodeId=e3df196816969, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=675, encryptionId=a4b96e542, topicName=1型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Thu Aug 14 08:11:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473740, encodeId=82f014e3740bc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Sep 11 02:11:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1759341, encodeId=934b1e59341c9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Feb 05 17:11:00 CST 2014, time=2014-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636736, encodeId=0c3a1636e36d9, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Mar 10 05:11:00 CST 2014, time=2014-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904933, encodeId=6a2e1904933cc, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64648, encryptionId=21f66464823, topicName=治疗方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ee4187, createdName=zhangjiqing, createdTime=Tue Jun 17 18:11:00 CST 2014, time=2014-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1968169, encodeId=e3df196816969, content=<a href='/topic/show?id=a4b96e542' target=_blank style='color:#2F92EE;'>#1型糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=675, encryptionId=a4b96e542, topicName=1型糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Thu Aug 14 08:11:00 CST 2014, time=2014-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473740, encodeId=82f014e3740bc, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Wed Sep 11 02:11:00 CST 2013, time=2013-09-11, status=1, ipAttribution=)]

相关资讯

Diabetes Care:胰岛素自身抗体水平有助提高T1D风险预测

为了评价将多个胰岛素自身抗体水平添加到糖尿病危险评分中是否可提高1型糖尿病(T1D)风险预测。来自佛罗里达迈阿密大学内分泌科的Sosenko博士等人进行了一项研究,研究发现,自身抗体水平在评估T1D风险中具有重要的作用。多个抗体水平可添加到能准确预测T1D风险的ABRS中。研究结果在线发表于2013年7月1日美国的《糖尿病治疗》(Diabetes Care)杂志上。 研究对象为784名“

Diabetologia:胰岛素泵治疗1型糖尿病儿童效优

一项关于胰岛素泵在1型糖尿病儿童中应用的大型长期研究表明,与多次皮下注射胰岛素相比,胰岛素泵连续皮下注射胰岛素可更好地进行升胰岛素控制,降低低血糖症的发生率。相关论文8月19日在线发表于《糖尿病病学》(Diabetologia)杂志。 该项观察性病例对照研究对比了345例接受胰岛素泵治疗和345例接受连续皮下注射胰岛素治疗的1型糖尿病儿童的差异。这些儿童平均年龄为11.5岁(2 —19

Diabetes Care:网络教程改善青少年糖尿病预后

  一项新的研究表明,参加网络心理教育项目可改善青少年1型糖尿病患者预后。两项网络教育计划都参与的青少年预后优于仅参加其中一项者。研究提示青少年患者既需要血糖管理方面的教育,又需要行为干预方面的指导。  与糖尿病相关的拓展阅读: 孕中期空腹血糖适合筛查我国妊娠期糖尿病 自体荧光测糖尿病微血管病变 Diabetes Care:青少年肥胖者发生糖尿病风险高于成人 Hype

J Med Life:1型糖尿病合并抑郁者转归较差

  抑郁是临床上最常见的精神疾病之一。多项研究显示抑郁症状可预测不同并发症(如心脏病、糖尿病、卒中及其他疾病)的发生,尽管如此,抑郁与糖尿病的关系仍未可知。   罗马尼亚布加勒斯特临床抑郁精神科Ladea M等人进行了一项研究,对严重抑郁障碍(MDD)合并1型或2型糖尿病患者进行评估,观察足量治疗时患者抑郁与糖尿病症状的改变。   研究入选43例患者,患者经诊断有MDD与1型或2型糖

Eur J Endocrinol:抑郁与1型糖尿病血糖控制不佳相关

  瑞典一项研究表明,抑郁与1型糖尿病患者糖化血红蛋白(HbA1c)水平>8.6%独立相关。这种相关性与血糖控制不佳和糖尿病并发症的已知风险因素肥胖和吸烟的重要性具有可比性。抑郁与HbA1c水平>8.6%的相关性在女性当中尤其明显。述情障碍(alexithymia)是一种相对稳定的个性特征,与抑郁相关。今后,在糖尿病患者的护理中,为了使HbA1c达标,应将精神因素与人体测量学(anthr

自体荧光测糖尿病微血管病变

     日本学者的一项研究显示,皮肤自体荧光(AF)值可反应1型糖尿病患者既往较长一段时期内的血糖控制情况,或可作为糖尿病微血管并发症的一项生物标志物。研究于2013年4月11日在线发表于《糖尿病护理》杂志。   研究旨在评估日本1型糖尿病患者中皮肤自体荧光(AF)值与既往血糖控制之间的关系,及其与微血管并发症进展之间的相关性。研究纳入241例患者,110例对照组患者。应用AF监测仪评估晚期

Baidu
map
Baidu
map
Baidu
map